PMHNP Collaborative Practice: What to Ask Before You Accept

1. Start with the state's practice environment

The American Association of Nurse Practitioners (AANP) groups states into three practice environments. In full practice states, NPs can evaluate, diagnose, order tests, and initiate treatment, including prescribing, under the authority of the board of nursing. In reduced practice states, the law requires a career-long regulated collaborative agreement, or it limits the setting of one or more elements of practice. In restricted practice states, the law requires career-long supervision, delegation, or team management by another provider. AANP's map was last updated in May 2026.

The category is only a starting point. States that grant full practice may still have transition-to-practice conditions, and the details inside a "reduced" state vary. Before your interviews, read the current rules on the nursing board's website for the state where you would practice, and the state of any patient you would see by telehealth.

Questions to ask:

• Which state or states would I practice in, including through telehealth?
• What agreement, if any, is required for me in each state, and has your team confirmed that with the board?
• Is there any transition period or hours requirement that applies to me?

2. Ask who the physician is and how available they are

State rules can be specific. Missouri's collaborative practice rule, for example, requires the collaborating physician (or a designated physician) to be immediately available for consultation at all times, in person or by telecommunications. Where an APRN diagnoses and initiates treatment for acutely or chronically ill or injured patients, Missouri law also requires the physician to be present at least once every two weeks, barring documented extraordinary circumstances, for chart review and direction. Texas requires a written prescriptive authority agreement that includes a plan for consultation and referral, a plan for patient emergencies, and a general process for communication between the APRN and physician.

Even where the law sets a minimum, the useful question is how collaboration works on a normal Tuesday. Ask:

• Who is my collaborating or supervising physician? Have they agreed to this arrangement, and how many other clinicians do they cover?
• How do I reach them for routine questions, and how fast do they usually respond?
• Who is the designated alternate when they are on vacation, ill, or unreachable?
• Will I meet the physician before I accept the offer?

Asking to speak with the physician is a reasonable request. Their answers will tell you more than any policy summary.

3. Understand chart review and meetings

Many agreements include chart review and scheduled meetings, and some states set the minimum. Under Missouri's rule, the collaborating physician must review at least 10% of the APRN's total services, and at least 20% of the cases where the APRN prescribed a controlled substance. Charts must be submitted for review at least every 14 days. Texas requires chart review (the APRN and physician set the number of charts) plus documented meetings at least monthly. The parties decide whether those meetings happen in person or remotely.

Ask how this works in practice:

• How are charts selected for review, and who does the selecting?
• How do I receive feedback, and is any review linked to my performance evaluation?
• When do meetings happen, are they on my schedule, and is that time protected?
• Who keeps the documentation the state requires?

A review process that is planned and scheduled is easier to sustain than one squeezed between visits.

4. Clarify controlled-substance authority and registrations

Much psychiatric prescribing involves controlled substances, such as stimulants for ADHD or benzodiazepines in some cases. Your authority to prescribe them depends on state law, your agreement (where one applies), and your federal registration.

The DEA treats nurse practitioners as "mid-level practitioners." They are authorized only to the extent their state permits. DEA rules require a separate registration for each principal place of practice where controlled substances are dispensed. DEA also lists states that require a separate state controlled-substance license before a federal registration is issued.

For telehealth roles, the DEA and HHS have extended the COVID-era telemedicine flexibilities through December 31, 2026. During that period, a DEA-registered practitioner may prescribe Schedule II–V medications by telemedicine without a prior in-person evaluation if specified conditions are met. A final DEA rule on special registrations for telemedicine was under federal regulatory review when we checked. Rules for 2027 may change, so ask how the employer is preparing.

Questions to ask:

• Which schedules does my agreement permit, and does it exclude any categories of medication?
• Which DEA and state controlled-substance registrations will I need, who pays for them, and who tracks renewals?
• Does the organization have controlled-substance policies (for example, monitoring program checks or treatment agreements), and who wrote them?
• For telehealth patients, how will the organization adapt when federal flexibilities change?

Clinical leaders set prescribing protocols. Your aim here is to understand the boundaries before you commit, not to negotiate clinical decisions in an interview.

5. Trace after-hours and escalation coverage

Collaboration matters most when a situation is urgent. Ask how the agreement connects to on-call coverage, crisis protocols, and hospital transfers. Find out whether the collaborating physician takes part in after-hours call, or whether a different person covers that time.

• Who do I contact after hours for a clinical question I cannot resolve alone?
• If I am on call, which physician backs me up, and how do I reach them?
• What is the emergency plan written into the agreement, and how does it match the clinic's crisis protocol?

For a deeper look at call arrangements, see PMHNP On-Call Expectations: Questions Before You Accept.

6. Ask what happens if the arrangement changes

Physicians leave, retire, and change roles. Missouri requires the collaborating physician to notify the medical board within 30 days of changes to collaborative arrangements. Both Missouri and Texas require periodic review of the written agreement. A gap in collaboration can affect whether you can keep seeing patients or prescribing in a reduced or restricted state.

• What is the contingency plan if my collaborating physician leaves?
• How quickly can a new agreement be signed, and who is responsible for the paperwork?
• Is there any fee for collaboration, and who pays it? Ask directly rather than assume.
• Will the agreement be shared with me before I start?

7. Put it in a decision record

One study of 177 novice NPs in primary care found that professional autonomy was a key factor in their intention to leave their jobs. That study does not cover psychiatry or experienced clinicians, but it supports a practical point: understand how much independence and support the role actually includes before you accept.

Keep a one-page record for each offer:

If an answer is unclear, ask a follow-up question before you decide. You can also compare roles side by side using How to Compare Permanent Clinician Offers. Another useful starting point is How PMHNPs Can Evaluate the Role Behind the Job Posting.